source
- OKYO Pharma CSO Raj Patil boosts stake to 20,030 sharesOKYO Pharma, a clinical stage biotech focused on neuropathic corneal pain and anterior segment eye diseases, disclosed that its chief scientific officer, Raj Patil, PhD, bought additional shares.…
- Australia's TGA adopts 23 international scientific guidelines from EMA, ICH and FDAThe Therapeutic Goods Administration (TGA) in Australia announced it has formally adopted 23 scientific guidelines. The guidelines come from the European Medicines Agency, the International Counci…